Perspectives on the therapeutic modulation of an alternative cell death, programmed necrosis (Review)

Cho,Young Sik

doi:10.3892/ijmm.2014.1716

Perspectives on the therapeutic modulation of an alternative cell death, programmed necrosis (Review)

Authors:
- Young Sik Cho
View Affiliations

Affiliations: College of Pharmacy, Keimyung University, Dalseo-gu, Daegu 704-701, Republic of Korea
Published online on: March 27, 2014 https://doi.org/10.3892/ijmm.2014.1716
Pages: 1401-1406

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In response to overwhelming external stimuli, cells are forced to die in different ways. By default, cells are prone to apoptosis, a programmed cell death through the activation of the caspase cascade. However, this process would be blocked if one of the proteins involved in executing apoptosis was genetically impaired or chemically inhibited, or if the apoptotic machinery was not properly operated under specific conditions, such as ischemia and microbial infection. To address these issues, the paradigm of programmed cell death needs to be revised; thus, an alternative form of cell death, programmed necrosis (termed necroptosis, through the caspase-independent pathway), which is distinct from apoptosis in many aspects, has recently been adopted. There is much interest in programmed necrosis as it is very closely associated with pathophysiological conditions, such as stroke, heart attack and septic shock. In an effort to identify target molecules of small compounds interfering with the signaling downstream of tumor necrosis factor-α (TNF-α), necrostatin-1 (Nec-1) was first identified to be a selective allosteric inhibitor of the death domain receptor-associated adaptor kinase, receptor interacting protein 1 (RIP1) in vitro. Since then, some novel scaffolds with selective and distinctive activity have been proposed. In this review, the significant advancement and state-of-art direction for the development of small molecules that can control programmed necrosis is discussed. Furthermore, the perspectives on novel strategies harnessing therapeutic targets identified thus far, are also discussed.

View Figures

View References

1	Iyer SS, Pulskens WP, Sadler JJ, et al: Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci USA. 106:20388–20393. 2009. View Article : Google Scholar : PubMed/NCBI
2	Xu Y, Huang S, Liu ZG and Han J: Poly(ADP-ribose) polymerase-1 signaling to mitochondria in necrotic cell death requires RIP1/TRAF2-mediated JNK1 activation. J Biol Chem. 281:8788–8795. 2006. View Article : Google Scholar : PubMed/NCBI
3	Petit F, Arnoult D, Viollet L and Estaquier J: Intrinsic and extrinsic pathways signaling during HIV-1 mediated cell death. Biochimie. 85:795–811. 2003. View Article : Google Scholar : PubMed/NCBI
4	Cho YS, Park SY, Shin HS and Chan FK: Physiological consequences of programmed necrosis, an alternative form of cell demise. Mol Cells. 29:327–332. 2010. View Article : Google Scholar : PubMed/NCBI
5	Rangamani P and Sirovich L: Survival and apoptotic pathways initiated by TNF-α: modeling and predictions. Biotechnol Bioeng. 97:1216–1229. 2007.
6	Lamkanfi M, Festjens N, Declercq W, Vanden Berghe T and Vandenabeele P: Caspases in cell survival, proliferation and differentiation. Cell Death Differ. 14:44–55. 2007. View Article : Google Scholar : PubMed/NCBI
7	Li Y, Yang X, Ma C, Qiao J and Zhang C: Necroptosis contributes to the NMDA-induced excitotoxicity in rat’s cultured cortical neurons. Neurosci Lett. 447:120–123. 2008.PubMed/NCBI
8	Scholz C, Wieder T, Stärck L, et al: Arsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway. Oncogene. 24:1904–1913. 2005. View Article : Google Scholar : PubMed/NCBI
9	Krumschnabel G, Ebner HL, Hess MW and Villunger A: Apoptosis and necroptosis are induced in rainbow trout cell lines exposed to cadmium. Aquat Toxicol. 99:73–85. 2010. View Article : Google Scholar : PubMed/NCBI
10	Hitomi J, Christofferson DE, Ng A, et al: Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell. 135:1311–1323. 2008. View Article : Google Scholar : PubMed/NCBI
11	Baritaud M, Cabon L, Delavallée L, et al: AIF-mediated caspase-independent necroptosis requires ATM and DNA-PK-induced histone H2AX Ser139 phosphorylation. Cell Death Dis. 3:e3902012. View Article : Google Scholar : PubMed/NCBI
12	Park S, Shin H and Cho Y: Shikonin induces programmed necrosis-like cell death through the formation of receptor interacting protein 1 and 3 complex. Food Chem Toxicol. 55:36–41. 2013. View Article : Google Scholar : PubMed/NCBI
13	Hsu TS, Yang PM, Tsai JS and Lin LY: Attenuation of cadmium-induced necrotic cell death by necrostatin-1: potential necrostatin-1 acting sites. Toxicol Appl Pharmacol. 235:153–162. 2009. View Article : Google Scholar : PubMed/NCBI
14	De Murcia G, Schreiber V, Molinete M, et al: Structure and function of poly(ADP-ribose) polymerase. Mol Cell Biochem. 138:15–24. 1994.
15	Lautier D, Lagueux J, Thibodeau J, Ménard L and Poirier GG: Molecular and biochemical features of poly (ADP-ribose) metabolism. Mol Cell Biochem. 122:171–193. 1993. View Article : Google Scholar
16	Gobeil S, Boucher CC, Nadeau D and Poirier GG: Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases. Cell Death Differ. 8:588–594. 2001. View Article : Google Scholar : PubMed/NCBI
17	Holler N, Zaru R, Micheau O, et al: Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 1:489–495. 2000. View Article : Google Scholar : PubMed/NCBI
18	Cho YS, Challa S, Moquin D, et al: Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell. 137:1112–1123. 2009. View Article : Google Scholar : PubMed/NCBI
19	He S, Wang L, Miao L, et al: Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-α. Cell. 137:1100–1111. 2009.PubMed/NCBI
20	Zhang DW, Shao J, Lin J, et al: RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science. 325:332–336. 2009. View Article : Google Scholar : PubMed/NCBI
21	Narayan N, Lee IH, Borenstein R, et al: The NAD-dependent deacetylase SIRT2 is required for programmed necrosis. Nature. 492:199–204. 2012. View Article : Google Scholar : PubMed/NCBI
22	Sun L, Wang H, Wang Z, et al: Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell. 148:213–227. 2012. View Article : Google Scholar : PubMed/NCBI
23	Galluzzi L and Kroemer G: Necroptosis: a specialized pathway of programmed necrosis. Cell. 135:1161–1163. 2008. View Article : Google Scholar : PubMed/NCBI
24	Baines CP: Role of the mitochondrion in programmed necrosis. Front Physiol. 1:1562010. View Article : Google Scholar : PubMed/NCBI
25	Wang Z, Jiang H, Chen S, Du F and Wang X: The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell. 148:228–243. 2012. View Article : Google Scholar : PubMed/NCBI
26	Teng X, Degterev A, Jagtap P, et al: Structure-activity relationship study of novel necroptosis inhibitors. Bioorg Med Chem Lett. 15:5039–5044. 2005. View Article : Google Scholar : PubMed/NCBI
27	Degterev A, Huang Z, Boyce M, et al: Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 1:112–119. 2005. View Article : Google Scholar : PubMed/NCBI
28	Degterev A, Hitomi J, Germscheid M, et al: Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol. 4:313–321. 2008. View Article : Google Scholar : PubMed/NCBI
29	Jagtap PG, Degterev A, Choi S, Keys H, Yuan J and Cuny GD: Structure-activity relationship study of tricyclic necroptosis inhibitors. J Med Chem. 50:1886–1895. 2007. View Article : Google Scholar : PubMed/NCBI
30	Wang K, Li J, Degterev A, Hsu E, Yuan J and Yuan C: Structure-activity relationship analysis of a novel necroptosis inhibitor, necrostatin-5. Bioorg Med Chem Lett. 17:1455–1465. 2007. View Article : Google Scholar : PubMed/NCBI
31	Teng X, Keys H, Jeevanandam A, et al: Structure-activity relationship study of [1,2,3]thiadiazole necroptosis inhibitors. Bioorg Med Chem Lett. 17:6836–6840. 2007.
32	Zheng W, Degterev A, Hsu E, Yuan J and Yuan C: Structure-activity relationship study of a novel necroptosis inhibitor, necrostatin-7. Bioorg Med Chem Lett. 18:4932–4935. 2008. View Article : Google Scholar : PubMed/NCBI
33	Smith CC, Davidson SM, Lim SY, Simpkin JC, Hothersall JS and Yellon DM: Necrostatin: a potentially novel cardioprotective agent? Cardiovasc Drugs Ther. 21:227–233. 2007. View Article : Google Scholar : PubMed/NCBI
34	You Z, Yang J, Takahashi K, et al: Reduced tissue damage and improved recovery of motor function after traumatic brain injury in mice deficient in complement component C4. J Cereb Blood Flow Metab. 27:1954–1964. 2007. View Article : Google Scholar : PubMed/NCBI
35	Choi JM, Park KM, Kim SH, et al: Effect of necrosis modulator necrox-7 on hepatic ischemia-reperfusion injury in beagle dogs. Transplant Proc. 42:3414–3421. 2010. View Article : Google Scholar : PubMed/NCBI
36	Gorman AM: Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling. J Cell Mol Med. 12:2263–2280. 2008. View Article : Google Scholar : PubMed/NCBI
37	Gukovskaya AS, Mareninova OA, Odinokova IV, et al: Cell death in pancreatitis: effects of alcohol. J Gastroenterol Hepatol. 21(Suppl 3): S10–S13. 2006. View Article : Google Scholar
38	Mareninova OA, Sung KF, Hong P, et al: Cell death in pancreatitis: caspases protect from necrotizing pancreatitis. J Biol Chem. 281:3370–3381. 2006. View Article : Google Scholar : PubMed/NCBI
39	Kennedy CL, Smith DJ, Lyras D, Chakravorty A and Rood JI: Programmed cellular necrosis mediated by the pore-forming α-toxin from clostridium septicum. PLoS Pathog. 5:e10005162009.
40	Yuan J: Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke. Apoptosis. 14:469–477. 2009. View Article : Google Scholar : PubMed/NCBI